Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific Organ Transplant Diagnostics Market
In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033. Numerous pivotal factors are driving growth in this industry, comprising a rise in chronic diseases leading to organ failure, increased utilization of transplant diagnostics, growing adoption of stem cell therapy, heightened demand for transplant diagnostic tests due to an uptick in leukemia cases, advantages stemming from advancements in molecular and genomic technologies in the transplant diagnostics realm, and the presence of favorable regulatory environments, including reimbursement schemes.
Market Introduction
The Asia-Pacific (APAC) organ transplant diagnostics market is experiencing significant growth, propelled by various factors. This includes the escalating incidence of chronic diseases leading to organ failure, the expanding utilization of transplant diagnostics, and a rising acceptance of stem cell therapy in the region. Additionally, the increasing prevalence of conditions like leukemia is driving demand for transplant diagnostic tests. The sector also benefits from advancements in molecular and genomic technologies, enhancing diagnostic capabilities. Furthermore, favorable regulatory conditions, such as reimbursement schemes, further stimulate market growth. With these dynamics at play, the APAC organ transplant diagnostics market is poised for notable expansion, catering to the growing demand for effective diagnostic solutions in organ transplantation procedures across the region.
Market Segmentation:
Segmentation 1: by Country
Growth/Marketing Strategy: The APAC organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities.
Competitive Strategy: The key players in the APAC organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the APAC organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific Organ Transplant Diagnostics Market
In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033. Numerous pivotal factors are driving growth in this industry, comprising a rise in chronic diseases leading to organ failure, increased utilization of transplant diagnostics, growing adoption of stem cell therapy, heightened demand for transplant diagnostic tests due to an uptick in leukemia cases, advantages stemming from advancements in molecular and genomic technologies in the transplant diagnostics realm, and the presence of favorable regulatory environments, including reimbursement schemes.
Market Introduction
The Asia-Pacific (APAC) organ transplant diagnostics market is experiencing significant growth, propelled by various factors. This includes the escalating incidence of chronic diseases leading to organ failure, the expanding utilization of transplant diagnostics, and a rising acceptance of stem cell therapy in the region. Additionally, the increasing prevalence of conditions like leukemia is driving demand for transplant diagnostic tests. The sector also benefits from advancements in molecular and genomic technologies, enhancing diagnostic capabilities. Furthermore, favorable regulatory conditions, such as reimbursement schemes, further stimulate market growth. With these dynamics at play, the APAC organ transplant diagnostics market is poised for notable expansion, catering to the growing demand for effective diagnostic solutions in organ transplantation procedures across the region.
Market Segmentation:
Segmentation 1: by Country
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest-of-Asia-Pacific
Growth/Marketing Strategy: The APAC organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities.
Competitive Strategy: The key players in the APAC organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the APAC organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.
Executive Summary
1 MARKET SCOPE
1.1 Key Questions Answered in the Report:
2 RESEARCH METHODOLOGY
2.1 Organ Transplant Diagnostics Market: Research Methodology
2.2 Data Sources
2.2.1 Primary Data Sources
2.2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling
3 ORGAN TRANSPLANT DIAGNOSTICS MARKET: OVERVIEW
3.1 Current Market Scenario
3.1.1 For Researchers
3.1.2 For Diagnostics
3.2 Market Footprint
3.3 COVID-19 Impact on Market
3.3.1 Impact on Operations
3.3.2 COVID-19 Impact: Current Scenario of Market
3.3.3 Pre- and Post-COVID-19 Impact Assessment
3.3.3.1 Pre-COVID-19 Phase
3.3.3.2 Post-COVID-19 Phase
4 ORGAN TRANSPLANT DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1 Overview
4.2 Legal Requirements and Framework in Asia-Pacific
4.2.1 China
4.2.2 Japan
4.3 Reimbursement Scenario
4.4 Patent Analysis
4.4.1 Patent Filing Trend (by Country)
4.4.2 Patent Filing Trend (by Year)
5 ORGAN TRANSPLANT DIAGNOSTICS MARKET: MARKET DYNAMICS
5.1 Impact Analysis
5.2 Market Drivers
5.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
5.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
5.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
5.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
5.3 Market Restraints
5.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
5.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
5.4 Market Opportunities
5.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
5.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant
6 REGION
6.1 Asia-Pacific
6.1.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
6.1.2 Market Sizing and Forecast
6.1.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
6.1.2.1.1 China
6.1.2.1.2 India
6.1.2.1.3 South Korea
6.1.2.1.4 Japan
6.1.2.1.5 Australia
6.1.2.1.6 Singapore
6.1.2.1.7 Rest-of-Asia-Pacific
7 COMPANY PROFILES
7.1 Overview
7.2 Manufacturers
1 MARKET SCOPE
1.1 Key Questions Answered in the Report:
2 RESEARCH METHODOLOGY
2.1 Organ Transplant Diagnostics Market: Research Methodology
2.2 Data Sources
2.2.1 Primary Data Sources
2.2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling
3 ORGAN TRANSPLANT DIAGNOSTICS MARKET: OVERVIEW
3.1 Current Market Scenario
3.1.1 For Researchers
3.1.2 For Diagnostics
3.2 Market Footprint
3.3 COVID-19 Impact on Market
3.3.1 Impact on Operations
3.3.2 COVID-19 Impact: Current Scenario of Market
3.3.3 Pre- and Post-COVID-19 Impact Assessment
3.3.3.1 Pre-COVID-19 Phase
3.3.3.2 Post-COVID-19 Phase
4 ORGAN TRANSPLANT DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1 Overview
4.2 Legal Requirements and Framework in Asia-Pacific
4.2.1 China
4.2.2 Japan
4.3 Reimbursement Scenario
4.4 Patent Analysis
4.4.1 Patent Filing Trend (by Country)
4.4.2 Patent Filing Trend (by Year)
5 ORGAN TRANSPLANT DIAGNOSTICS MARKET: MARKET DYNAMICS
5.1 Impact Analysis
5.2 Market Drivers
5.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
5.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
5.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
5.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
5.3 Market Restraints
5.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
5.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
5.4 Market Opportunities
5.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
5.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant
6 REGION
6.1 Asia-Pacific
6.1.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
6.1.2 Market Sizing and Forecast
6.1.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
6.1.2.1.1 China
6.1.2.1.2 India
6.1.2.1.3 South Korea
6.1.2.1.4 Japan
6.1.2.1.5 Australia
6.1.2.1.6 Singapore
6.1.2.1.7 Rest-of-Asia-Pacific
7 COMPANY PROFILES
7.1 Overview
7.2 Manufacturers
LIST OF FIGURES
Figure 1: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 2: Organ Transplant Diagnostics Market, Impact Analysis
Figure 3: Asia-Pacific Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
Figure 4: Asia-Pacific Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
Figure 5: Asia-Pacific Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 6: Asia-Pacific Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 7: Asia-Pacific Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
Figure 8: Organ Transplant Diagnostics Market: Research Methodology
Figure 9: Primary Research Methodology
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 13: Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
Figure 14: Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
Figure 15: Organ Transplant Diagnostics Market, Impact Analysis
Figure 16: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
Figure 17: Number of Solid Organ Transplants, 2017-2021
Figure 18: Applications of Stem Cell Therapy
Figure 19: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
Figure 20: Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
Figure 21: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 22: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
Figure 23: China Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 24: India Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 25: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 26: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 27: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 28: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 29: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 30: Total Number of Companies Profiled
Figure 31: Organ Transplant Diagnostics Market Overview, Key Companies
Figure 1: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 2: Organ Transplant Diagnostics Market, Impact Analysis
Figure 3: Asia-Pacific Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
Figure 4: Asia-Pacific Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
Figure 5: Asia-Pacific Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 6: Asia-Pacific Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 7: Asia-Pacific Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
Figure 8: Organ Transplant Diagnostics Market: Research Methodology
Figure 9: Primary Research Methodology
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 13: Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
Figure 14: Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
Figure 15: Organ Transplant Diagnostics Market, Impact Analysis
Figure 16: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
Figure 17: Number of Solid Organ Transplants, 2017-2021
Figure 18: Applications of Stem Cell Therapy
Figure 19: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
Figure 20: Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
Figure 21: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 22: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
Figure 23: China Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 24: India Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 25: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 26: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 27: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 28: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 29: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 30: Total Number of Companies Profiled
Figure 31: Organ Transplant Diagnostics Market Overview, Key Companies
LIST OF TABLES
Table 1: Key Questions Answered in the Report
Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
Table 3: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
Table 4: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021
Table 1: Key Questions Answered in the Report
Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
Table 3: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
Table 4: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021
